ERS Genomics & abm enter into CRISPR/Cas9 Licensing Agreement This License allows abm to develop and commercialize products using CRISPR/Cas9 technology. Dublin, Ireland and Vancouver, Canada, 1st June 2023: ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Applied Biological Materials Inc (‘abm,’). This is a.Read Full Article
Schedule time with ERS
‘If you’re using or plan to use CRISPR/Cas9
technology, you need a License
from ERS Genomics.’
Connect with us @ Bio Boston in June.
Getting a license is easy, fast & flexible.
Jon Kratochvil, Vice President, ERS Genonics.